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Proteinase II, a snake venom metalloproteinase from Crotalus adamanteus, has been crystallized. The 
crystals are of the trigonal space group P 3112 (or P 3212), diffract well beyond 2 A and are suitable for 
X-ray crystal structure analysis. 
Protein crystallography Metalloproteinase Snake venom Limited proteolysis 
1. INTRODUCTION 
A metalloproteinase, designated proteinase II, 
was isolated in a homogeneous tate from Crotalus 
adamanteus venom, its properties and activities 
described [l]. By SDS gel electrophoresis, its A4, is 
-24 000. It is readily inactivated by EDTA, is 
unaffected by diisopropyl fluorophosphate, and 
does not require thiol compounds for activation. 
By its inhibition profile, Zn2+ and Ca2+ seem to be 
essential for activity [l]. Proteinase II hydrolyzes 
general protein substrates such as casein and 
globin very poorly, and shows no activity on 
typical synthetic substrates for the serine pro- 
teinases trypsin, chymotrypsin, plasmin, thrombin 
or elastase. Thus proteinase II has all characteris- 
tics of a metalloproteinase, but does not digest 
typical substrates for thermolysin, carboxypepti- 
dase A or B, Pseudomonas aeruginosa elastase or 
Clostridium histolyticum collagenase, and shows 
no activity on native collagen or elastin. Rather, 
the specificity of proteinase II seems directed 
towards enzymatic inactivation of native (human) 
plasma proteinase inhibitors [2,3]. Proteinase II in 
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catalytic amounts cleaves the Ala3so-Met3sl bond 
[4,5] in human plasma cul proteinase inhibitor and 
the Ala375-Ser376 bond [6] in human plasma anti- 
thrombin III resulting in inactivation of these in- 
hibitors. These bonds are 8 and 9 residues, respec- 
tively, N-terminal of the reactive site bonds of 
those inhibitors [5,7] 
2. MATERIALS AND METHODS 
Proteinase II from Crotalus adamanteus venom 
(obtained from Miami Serpentarium) was 
prepared as in [l] except that a final step of gel 
filtration on S-200 Sephacryl (Pharmacia) in 
0.05 M glycine-0.2 M NaCl (pH 9.5) was incor- 
porated to remove a trace amount of higher-M, 
contaminant. The purified enzyme was then 
dialyzed against 0.01 M sodium borate-O.002 M 
CaC12 (pH 8.0) concentrated and stored as a 
suspension in 80% saturated (NH& SO4. The en- 
zyme retains full activity under these conditions. 
Crystallization was achieved in (NH& SO4 at 
4°C with a solution containing 20 mg protein/ml, 
buffered with 0.1 M phosphate and saturated with 
CaC12, using the vapour diffusion technique and 
methods in [8]. The crystal density was determined 
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in a Ficoll 400 (Pharmacia) gradient as in [9] but 
with a density read after 2 min centrifugation at 
10 000 x g. SDS gel electrophoresis was performed 
on 7.5% polyacrylamide gels in 0.1 M 
Tris-phosphate buffer at pH 6.8 in the presence of 
0.1% SDS and 8 M urea. The samples were prein- 
cubated in the presence of 1% mercaptoethanol 
and 1% SDS in the same buffer at 90°C for 5 min 
before application to the gels. Direct M, deter- 
mination by sedimentation equilibrium in a Spinco 
Model E analytical ultracentrifuge (Beckman) was 
kindly performed by Dr H. Priess (Max-Planck- 
Institut fiir Biochemie, Martinsried). 
3. RESULTS AND DISCUSSION 
In 1.8 M (NHa)z SO4 at pH 5, triangular prism- 
shaped crystals (fig. 1) could be grown to a max- 
imal length of 1 mm and up to 0.3 mm diam. 
Precession photographs how the Laue group 3 m, 
systematic extinctions along 001 for 1 = 3n + 1 and 
1=3n+2(n=0,1,2...)andmmsymmetryofthe 
h01 zones. Consequently these crystals belong to 
the trigonal space group P3112 or to its enan- 
tiomorphic space group P3212. The unit cell con- 
stants as measured from zero layer precession 
photographs are a = b = 73.3 A, c = 95.8 A, 
& =p= 90”, y = 120”. Due to SDS gel elec- 
trophoresis, the crystalline material is identical 
with the original proteinase II material and 
migrates like a normally behaving protein of Mr 
24 000 (the sedimentation equilibrium runs in- 
dicate A4,22 400 f 2000 under the assumption of a 
partial specific volume of 0.74 ml/g for this pro- 
Fig. 1. Trigonal proteinase II crystal of approximate size 
0.8 x 0.2 x 0.1 mm3. 
teinase). Because of a crystal density of 
1.20 f 0.01 g/ml determined in the aqueous Ficoll 
gradient for 4 different crystals, the protein con- 
tent of the asymmetric unit should have 
A4, 34 500 f 2000. Thus, the asymmetric unit may 
either contain one or two molecules. If this pro- 
teinase, however, behaves normally with respect o 
the M, determination methods applied, only one 
molecule/asymmetric unit is consistent with the 
crystal volumes/protein M, unit observed [lo]. The 
reason for this uncertainty is unclear. These 
trigonal crystals are stable in 3 M (NH& SO4 up 
to pH 9 (i.e., in the optimal pH-range of this en- 
zyme) and they tolerate either EDTA or Zn2+, pro- 
perties which could be helpful for the preparation 
of heavy metal derivatives. They diffract well to 
Bragg spacings beyond 2.0 A and prove to be quite 
suitable for X-ray structure analysis. The collec- 
tion of intensity data from these trigonal crystals is 
now under way in our laboratory. 
Besides these well-diffracting trigonal crystals, 
which could only be grown at pH 5, another 
crystal modification growing in thin stacked 
plates (fig. 2) of approximate dimensions 
0.5 x 0.3 x 0.03 mm was frequently observed in 
1.8-2.0 M (NH& SO4 between pH 5-8. These 
crystals show reflections to -3 A resolution, but 
are considerably disordered and not suitable for X- 
ray diffraction studies. 
At present the metalloproteinases for which 
3-dimensional structures are known are ther- 
molysin [ 1 I], carboxypeptidases A [ 121 and B [ 131, 
and a D-alanyl-D-alanine-cleaving carboxypepti- 
dase from Streptomyces albus [14]. With the ex- 
Fig. 2. Stacked plates of the second (presumably 
monoclinic) crystal form of proteinase II. 
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ception of the close homology between both 
bovine carboxypeptidases, these metalloenzymes 
including proteinase II seem to be unrelated with 
respect to molecular size and chain fold. Never- 
theless, the molecular parts involved in the 
catalytic event seem to have several features in 
common. Thus these proteinase II crystals suggest 
not only a new proteinase fold, but an alternative 
investigation of metalloproteinase reaction 
mechanism. 
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PI 
The unique specificity of this proteinase II must 
reside in the specific contouring of the substrate- 
binding surface. Since the structure of a split 
human al proteinase inhibitor is now being deter- 
mined [ 151, knowledge of the crystal structure of 
proteinase II could help us to understand the 
specific and selective cleavage on a structural basis. 
Finally, no previous crystal structure determina- 
tions have been reported for any reptilian or snake 
venom proteinase. Comparison of proteinase II 
with metalloproteinases from other sources will be 
important in determining the extent of structural 
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